TB Patients' vaccine response under the microscope
NCT ID NCT05571735
First seen Apr 30, 2026 · Last updated May 09, 2026 · Updated 2 times
Summary
This study looks at how the immune systems of people being treated for tuberculosis respond to COVID-19 vaccines compared to healthy people. About 108 adults (54 with TB and 54 healthy) will receive one or two doses of a standard COVID-19 vaccine. Researchers will measure antibody and cell-based immune responses over about a year to see if TB treatment affects vaccine protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shoklo Malaria Research Unit (SMRU)
RECRUITINGMae Ramat, Changwat Tak, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.